Literature DB >> 20136083

In vitro digestion of Cry1Ab proteins and analysis of the impact on their immunoreactivity.

Valeria Guimaraes1, Marie-Françoise Drumare, Didier Lereclus, Michel Gohar, Patricia Lamourette, Marie-Claire Nevers, Marie-Lisa Vaisanen-Tunkelrott, Hervé Bernard, Blanche Guillon, Christophe Créminon, Jean-Michel Wal, Karine Adel-Patient.   

Abstract

A pepsin resistance test performed at pH 1.2 and with high pepsin to protein ratio is one of the steps of the weight-of-evidence approach used for assessment of allergenicity of new proteins. However, the use of other in vitro digestibility tests, performed in more physiologically relevant conditions and in combination with immunological assays so as to increase the value of the information gained from the studies of stability of a novel protein to digestion for the overall allergenicity assessment, has been proposed. This study then aimed to investigate the stability to digestion of Cry1Ab protoxin and toxin, insecticidal proteins expressed in genetically modified crops, using simulated gastric fluid (SGF) at different pH values and pepsin-to-substrate ratios, in the presence or absence of physiological surfactant phosphatidylcholine (PC). Electrophoresis and immunoblot patterns and residual immunoreactivity of digesta were analyzed. Although Cry1Ab protoxin is extensively degraded at pH 1.2 with high pepsin-to-protein ratio, it is only slightly degraded at pH 2.0 and conserved its immunoreactivity. Furthermore, Cry1Ab proteins were demonstrated to be stable in a more physiologically relevant in vitro digestibility test (pH 2.5, pepsin-to-substrate ratio 1:20 (w/w) with PC). Factors such as pH, SGF composition, and pepsin-to-substrate ratio then greatly influence the digestion of Cry1Ab proteins, confirming that new and more physiologically relevant in vitro digestibility tests should be also considered to study the relationship between the resistance of a protein to digestion and its allergenicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20136083     DOI: 10.1021/jf903189j

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  8 in total

1.  Immunological and metabolomic impacts of administration of Cry1Ab protein and MON 810 maize in mouse.

Authors:  Karine Adel-Patient; Valeria D Guimaraes; Alain Paris; Marie-Françoise Drumare; Sandrine Ah-Leung; Patricia Lamourette; Marie-Claire Nevers; Cécile Canlet; Jérôme Molina; Hervé Bernard; Christophe Créminon; Jean-Michel Wal
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

Review 2.  The food and environmental safety of Bt crops.

Authors:  Michael S Koch; Jason M Ward; Steven L Levine; James A Baum; John L Vicini; Bruce G Hammond
Journal:  Front Plant Sci       Date:  2015-04-29       Impact factor: 5.753

3.  Bt-maize (MON810) and non-GM soybean meal in diets for Atlantic salmon (Salmo salar L.) juveniles--impact on survival, growth performance, development, digestive function, and transcriptional expression of intestinal immune and stress responses.

Authors:  Jinni Gu; Anne Marie Bakke; Elin C Valen; Ingrid Lein; Åshild Krogdahl
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

Review 4.  Possible health impacts of Bt toxins and residues from spraying with complementary herbicides in genetically engineered soybeans and risk assessment as performed by the European Food Safety Authority EFSA.

Authors:  Christoph Then; Andreas Bauer-Panskus
Journal:  Environ Sci Eur       Date:  2017-01-11       Impact factor: 5.893

5.  Transcriptomic Analysis of Intestinal Tissues from Two 90-Day Feeding Studies in Rats Using Genetically Modified MON810 Maize Varieties.

Authors:  Jutta Sharbati; Marc Bohmer; Nils Bohmer; Andreas Keller; Christina Backes; Andre Franke; Pablo Steinberg; Dagmar Zeljenková; Ralf Einspanier
Journal:  Front Genet       Date:  2017-12-19       Impact factor: 4.599

6.  Humoral and cellular immune response in Wistar Han RCC rats fed two genetically modified maize MON810 varieties for 90 days (EU 7th Framework Programme project GRACE).

Authors:  Jana Tulinská; Karine Adel-Patient; Hervé Bernard; Aurélia Líšková; Miroslava Kuricová; Silvia Ilavská; Mira Horváthová; Anton Kebis; Eva Rollerová; Júlia Babincová; Radka Aláčová; Jean-Michel Wal; Kerstin Schmidt; Jörg Schmidtke; Paul Schmidt; Christian Kohl; Ralf Wilhelm; Joachim Schiemann; Pablo Steinberg
Journal:  Arch Toxicol       Date:  2018-05-31       Impact factor: 5.153

7.  Deep analysis of immune response and metabolic signature in children with food protein induced enterocolitis to cow's milk.

Authors:  Karine Adel-Patient; Guillaume Lezmi; Florence Anne Castelli; Sibylle Blanc; Hervé Bernard; Pascale Soulaines; Pascale Dumond; Sandrine Ah-Leung; Florence Lageix; Delphine de Boissieu; Naima Cortes-Perez; Stéphane Hazebrouck; François Fenaille; Christophe Junot; Christophe Dupont
Journal:  Clin Transl Allergy       Date:  2018-09-28       Impact factor: 5.871

8.  Investigations of immunogenic, allergenic and adjuvant properties of Cry1Ab protein after intragastric exposure in a food allergy model in mice.

Authors:  Monica Andreassen; Thomas Bøhn; Odd-Gunnar Wikmark; Johanna Bodin; Terje Traavik; Martinus Løvik; Unni Cecilie Nygaard
Journal:  BMC Immunol       Date:  2016-05-04       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.